Binder profile
ZINC142512519
Virtual-screening candidate from ZINC.
Bound to: PA1155 — ribonucleotide-diphosphate reductase subunit beta
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC142512519- UniProt (similar protein)
P69924- Tanimoto
- 0.818
- Target protein
- PA1155
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 498.2
- LogP ≤ 5 0.21
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 227.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1cn([C@@H]2C[C@H](O)[C@H](CO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O)O2)c(=S)[nH]c1=OCc1cn([C@@H]2C[C@H](O)[C@H](CO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O)O2)c(=S)[nH]c1=O
InChI=1S/C10H17N2O13P3S/c1-5-3-12(10(29)11-9(5)14)8-2-6(13)7(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h3,6-8,13H,2,4H2,1H3,(H,18,19)(H,20,21)(H,11,14,29)(H2,15,16,17)/t6-,7-,8-/m0/s1InChI=1S/C10H17N2O13P3S/c1-5-3-12(10(29)11-9(5)14)8-2-6(13)7(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h3,6-8,13H,2,4H2,1H3,(H,18,19)(H,20,21)(H,11,14,29)(H2,15,16,17)/t6-,7-,8-/m0/s1
RPGRVLDVCSQZTK-FXQIFTODSA-NRPGRVLDVCSQZTK-FXQIFTODSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- TTP
- Homolog
- P69924
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC142512519 →
- ZINC ZINC20 ZINC142512519 →
- UniProt UniProt P69924 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC142512519”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1155.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).